Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Brooks Laboratories Limited (NSE: BROOKS), ISIN INE650L01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BROOKS last traded at ₹61.27 (+3.23%), with a 52-week range of ₹36.90 to ₹149.05 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 52.62%, FIIs 0.00%, DIIs 10.38%, mutual funds 9.90%.
EquiSense Score (ECS): 54/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.